Genecast

Genecast is a precision oncology diagnostics company specializing in cancer detection, treatment selection, prognosis, and recurrence monitoring.

The company offers a comprehensive range of molecular diagnostic services that utilize next-generation sequencing (NGS), liquid biopsy, and bioinformatics. Their services include NGS, multiplex IHC, immuno-oncology gene expression profiling, TCR sequencing, DNA methylation testing, circulating tumor cell testing, and ctDNA liquid biopsy. Genecast supports clinical decision-making for personalized medicine by covering over 20 cancer types. They have developed China’s first molecular residual disease detection service, Genecast MRD – Lung. The company collaborates with hospitals, clinical laboratories, research institutions, and pharmaceutical companies, providing services in biomarker discovery, clinical trial support, and companion diagnostics development. Genecast is recognized as a leader in precision medicine and companion diagnostics in China, holding various certifications such as CAP, ISO, CE-IVD, and NMPA.